Acceleron Pharma Inc.
ENDOGLIN PEPTIDES TO TREAT FIBROTIC DISEASES

Abstract:

In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to treat fibrotic disorders.